Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsSelectHealth formulary coverage & prior auth | Ope…
    Ask Trek AI about this page
    CurrentSelectHealthPolicy N/A

    Prescription drug list (formulary) — Coverage criteria

    Customize your policy alerts

    Sign up for all SelectHealth policy alerts

    Know when SelectHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Summary of commonly prescribed drugs covered by SelectHealth plans, tiering, coverage limits, and requirements (e.g., preauthorization, step therapy, quantity limits) for members and providers.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerSelectHealth
    PolicyPrescription drug list (formulary) — Coverage criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionObtain prior authorization before dispensing drugs flagged (PA) to ensure coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    monthlyformulary review cadence
    90-daymaintenance drug supply option
    PA requiredPA requirement
    ST appliesStep therapy usage
    PA, QL, ST, M, AGErequirement codes present
    NCapplicable state

    Coverage Criteria

    Drugs that are not covered may still be considered for coverage on a case-by-case basis. To request an exception you, the prescribing physician, or the dispensing pharmacy must submit a Drug Coverage Exception Form and demonstrate that coverage is medically necessary. Requests are reviewed individually and approved only when the documented medical necessity supports coverage.

    This segment does not list any explicit exclusion conditions beyond the standard formulary flags. Individual line items include requirement flags (e.g., (PA), (QL), (M), (ST), (AGE)) but no separate, named exclusions are specified in the excerpt.

    Within this excerpt there are no statements declaring specific drugs or uses as not medically necessary. Coverage determinations reference requirement flags (such as (M) for medical necessity) that trigger review, but no standalone 'not medically necessary' declarations appear in the provided text.

    Coding and Requirement Flags

    Formulary requirement flagsmixed
    (PA)Prior Authorization
    (QL)Quantity Limit
    (M)Medical Benefit / Medical necessity indicator
    Additional requirement flagsmixed
    (ST)Step Therapy
    (AGE)Age limit applies
    Formulary requirement codesmixed
    PAPrior authorization required (indicator shown next to some drugs)
    QLQuantity limits (indicator shown next to many drugs)
    MMedical necessity review indicator
    AGEAge limit indicator
    STStep therapy indicator
    Assure / Free Libre / Freestyle device/test entries — composite flags
    Assure 3 TesRequirements & Limits = 3 (ST)(QL)(M)(AGE)
    Assure 4 TesRequirements & Limits = (PA)(QL)(M) and elsewhere listed as 3 (ST)(QL)(M)(AGE)
    Free Libre2 / Free Libre3 / Freestyle entriesListed with composite requirement flags including (ST)(QL)(M)(AGE) where indicated on device/test lines
    Assure Ii / Assure Prism / Assure ProMultiple Assure device/test entries shown with (PA)(QL)(M) or (M) depending on the specific product line
    Age- or quantity-based limits (AGE / QL)
    Vaccine age or quantity limitsSeveral vaccine entries carry (QL) or (AGE) (e.g., Comirnaty 5- = (QL); Gardasil 9 = (AGE); Pneumovax 23 = (AGE))
    Pediatric iron and vitamin preparationsIron Inf-Tod Dro and other pediatric iron products = (QL)(AGE); Pediatric Dro entries explicitly show (QL)(AGE)
    Products with explicit (AGE) or (QL)Many formulary lines specify (AGE) or (QL) — the flag on each drug line denotes the applicable age or quantity-based limit

    Provider Actions, Authorization & Documentation

    Prior Authorization

    Preauthorization required

    Coverage of certain drugs requires preauthorization — items marked (PA) must have prior authorization before the plan will cover them. If preauthorization is not obtained, the member may be responsible for the full retail cost.

    • Examples: Repatha Injectable, Repatha Sure Injectable, Trikafta, many specialty injectables and test supplies are flagged (PA).
    • Preauthorization is commonly required for high-cost specialty agents and certain injectables; see the formulary entries for (PA) flags.
    Documentation Required

    Prior authorization and requirement indicators

    Prior authorization and other requirement flags (PA, QL, ST, M, AGE) appear next to drug entries and determine coverage conditions. Providers must review these flags on the formulary and submit the appropriate documentation when requesting coverage.

    Background

    The formulary is maintained and reviewed by a clinical pharmacy team together with physician reviewers who evaluate each product for efficacy, safety, and cost‑effectiveness. Inclusion on the formulary reflects that review, but coverage for a given prescription still depends on any plan-specific requirements (for example, prior authorization, step therapy, quantity limits, medical necessity, or age limits).

    Definitions and Flag Key

    Maintenance drug
    DefinitionMaintenance drug: These drugs may allow you to get a 90-day supply, for your convenience.
    Typical implicationMember may be eligible for extended (90-day) supply when agent is designated (M)
    DocumentationSee drug line for (M) indicator to confirm maintenance status and supply option
    Step Therapy (ST) — definition
    DefinitionStep Therapy (ST): Drugs that require step therapy are covered only after you have tried an alternative therapy and it didn't work or caused adverse reactions.
    Coverage requirementDocumented trial and failure or intolerance of the required alternative is needed before coverage of the ST drug

    Step Therapy Details

    Formulary flagMeaning / requirement
    (ST)
    Step therapy — drug requires trial and failure or intolerance of specified alternative therapy before coverage is approved; documentation must be provided.
    Example drugRequirements & Limits
    Midodrine
    Shown with (ST) indicating step therapy is required prior to coverage.
    Pitavastatin
    Shown with (ST)(QL)(M) on formulary lines — step therapy required before coverage.
    Dilt-Xr
    Listed among agents with (ST) — step therapy requirement applies.
    Device / productFormulary flags
    Soliqua Injectable
    Requirements & Limits = (ST)(QL)(M) — step therapy must be met prior to coverage.
    Assure 3 / Assure 4 test supplies
    Assure 3 Tes and Assure 4 Tes shown with 3 (ST)(QL)(M)(AGE) indicating step therapy applies to these entries.
    Free Libre2 / Free Libre3 / Freestyle entries
    Freestyle/ Freesty Libr and Free Libre kits listed with (ST)(QL)(M)(AGE) flags — step therapy requirement present.
    Formulary entryNotes on (ST)
    Estradiol (select formulations)
    Some estradiol entries show (ST) among other flags — step therapy must be satisfied prior to coverage.
    Laxatives category
    LAXATIVES entries include (ST)(QL)(M) for some products, indicating step therapy requirement for coverage.
    Category / drugST indication
    Metaxalone Tablet
    Requirements & Limits = (ST) — step therapy applies.
    Xhance (nasal) / Brimonidine
    Xhance Mis shows (ST)(QL)(M) on formulary lines — step therapy required where indicated.
    Topiramate and related seizure agents
    Some seizure/neurology entries list (ST)(QL)(M) indicating step therapy is required prior to coverage.
    Listed productStep therapy (ST) status
    Nicotine / smoking cessation products
    Multiple nicotine products and quit aids display (ST)(QL)(M)(AGE) on formulary lines — step therapy indicated where shown.
    Levothyroxin / thyroid products
    Levothyroxin listed with (ST)(QL)(M) — step therapy required before coverage for entries that include (ST).
    General policy statement
    As defined in the formulary, (ST) flags indicate the member must try and fail specified alternatives; coverage is contingent on satisfying step therapy requirements.

    Quantity Limits

    Quantity limits — general notice and examples
    General QL ruleQuantity limits apply where (QL) is indicated in the formulary list; check the drug line for the specific limit.
    Genotropin InjectableGenotropin Injectable requirements include (PA)(QL)(M) indicating both PA and QL apply alongside medical necessity review.
    Fluorouracil and other dermatologic agentsFluorouracil is shown with (PA)(QL); several topical and misc. products include (QL) on their lines.
    Multiple entries flagged with (QL)
    Multiple QL-flagged entriesNumerous products across categories (cardiovascular, diabetes, dermatology) display (QL); see each formulary line for exact limits.
    Pitavastatin examplePitavastatin Tablet shows (ST)(QL)(M) — includes quantity limit in addition to step therapy and medical necessity flags.
    Policy Summary
    PayerSelectHealth
    PolicyPrescription drug list (formulary) — Coverage criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionObtain prior authorization before dispensing drugs flagged (PA) to ensure coverage.
    SourceLink
    On This Page
    Coverage CriteriaCoding and Requirement FlagsProvider Actions, Authorization & DocumentationBackgroundDefinitions and Flag KeyStep Therapy DetailsQuantity Limits
  1. (PA) = Prior authorization required; (QL) = quantity limits; (ST) = step therapy; (M) = medical necessity documentation; (AGE) = age-based limits.
  2. Examples: Trikafta = (PA)(QL)(AGE)(M); many diabetes supplies and injectables show (PA)(QL)(M).
  3. Denial Risk

    Age-based coverage limits

    Some formulary entries include explicit age limits (AGE). Claims for members outside the indicated age ranges may be denied if age-based criteria are not met.

    • Examples: Vaccines (Gardasil 9, Ipol) and certain pediatric or geriatric therapies include (AGE) flags.
    • When (AGE) is present, include the patient’s date of birth and supporting clinical rationale if requesting an exception.
    Denial Risk

    Denial triggers for unmet requirements

    Claims or pharmacy requests may be denied if preauthorization, step therapy, quantity limits, age restrictions, or required documentation are not met. Absence of PA for (PA)-flagged drugs is a common denial trigger.

    • Denial triggers include: no prior authorization for (PA) drugs; exceeding (QL) without approval; failure to document required step-therapy trials (ST); missing medical necessity (M) documentation; or age outside (AGE) limits.
    • If a claim is denied, providers and members may follow the coverage exception process (Drug Coverage Exception Form).
    Prior Authorization

    Prior authorization indicated

    Prior authorization flags (PA) throughout the formulary indicate the plan requires approval before filling. Providers should initiate PA requests promptly to avoid claim denials and member financial responsibility.

    • Commonly PA-required items: specialty injectables, oncology agents, certain diagnostic test supplies and select topical agents.
    • PA requirements apply to both pharmacy-dispensed drugs and some medical benefit products (injectables, devices).
    Note

    Coverage exception process

    To request coverage for a noncovered drug or to appeal a denied claim, members, physicians, or pharmacies must submit a Drug Coverage Exception Form with supporting documentation showing medical necessity.

    • The Drug Coverage Exception Form is available on the payer website.
    • Include clinical notes, previous treatment history, and any test results that support the exception request.
    Documentation Required

    Documentation for flagged drugs

    Providers must supply supporting documentation when requesting PA, QL overrides, or exceptions. Documentation should demonstrate medical necessity, prior trials (for ST), dosing and quantity rationale, and patient age when (AGE) applies.

    • Documentation examples: prior therapy trial records (for ST), treatment failure/intolerance notes, labs or diagnostic reports, and prescriptions or dispensing history.
    • Quantity limit (QL) exceedance requests should include justification for higher dosing or duration; medical necessity (M) items require clinical notes.
    Step Therapy

    Step therapy requirement

    Step therapy (ST) requires documented trial and failure or intolerance of specified alternative therapies before the requested drug will be covered. Items marked (ST) will be denied if required prior steps are not shown.

    • Examples of ST: Pitavastatin and other agents noted with (ST); some inhaled and topical products also require step therapy.
    • When submitting PA for an ST item, include dates and outcomes of prior medication trials and reasons for switching.
    Common useStep therapy most often applies to brand-name drugs; check the drug line for (ST) flag
    Prior Authorization (PA)
    DefinitionPrior Authorization (PA): Coverage requires approval before the benefit is payable; items marked (PA) require PA prior to dispensing to ensure coverage.
    ConsequenceWithout required PA, the member may be responsible for full retail price or claim may be denied
    Where shownPA indicator appears next to many injectable and specialty agents and on device/test product lines
    Quantity Limit (QL)
    DefinitionQuantity Limit (QL): Limits on the amount of drug covered per time period; items marked (QL) have quantity limits.
    Exceeding limitsPreauthorization is required if the medication exceeds the plan limits; documentation should support medical necessity for higher quantities
    Where shownQL appears on many drug lines (including vaccines, injectables, and OTC-type products) to indicate a per-claim or per-period limit
    Step Therapy (ST) — alternate reference
    DefinitionStep Therapy (ST): Requirement to try specified alternatives before the listed drug; items marked (ST) are subject to step therapy requirements.
    Provider actionProviders must document trials of required therapies and failure/intolerance to satisfy the ST condition
    ExamplesST appears on diabetes supplies and other product lines (see Assure, Soliqua, Levothyroxin examples)
    M — Medical necessity flag
    DefinitionM (Medical necessity flag): Indicates medical indication or medical necessity review is required for the drug line.
    ImplicationClaims may require supporting documentation of medical necessity when (M) is present
    Use on formulary(M) appears frequently alongside PA, QL, and ST on specialty and high-cost agents
    AGE — Age-based coverage limitation
    DefinitionAGE: Age-based coverage limitation indicated by (AGE) on the drug line.
    Claim impactClaims outside specified age bounds risk denial at adjudication when (AGE) is shown
    Common occurrences(AGE) appears on dermatologic agents, vaccines, pediatric supplements, and other product lines in the formulary
    Flags used in Requirements & Limits
    (PA)Prior Authorization — coverage requires approval before benefit is payable; appears on many injectable/specialty lines.
    (QL)Quantity Limit — limits on amount covered per time period; preauthorization required if limits are exceeded.
    (M)Medical necessity review — indicates medical indication or need for documentation.
    (ST)Step Therapy — coverage only after trial and failure or intolerance of specified alternative therapy.
    (AGE)Age limit — indicates age-based coverage restriction that may cause denial if outside bounds.
    Xigduo Xr and othersXigduo Xr Tablet listed with (QL)(M); check individual lines for QL specifics.
    Fluorouracil — requirements
    FluorouracilFormulary line: Fluorouracil, Drug Tier = 2; Requirements & Limits = (PA)(QL)
    ContextAppears in dermatologicals section where both PA and QL are applied to this topical agent
    Provider actionObtain PA and observe QL for coverage; documentation may be needed for quantities beyond limits
    Trulicity Injectable — requirements
    Trulicity InjectableFormulary line: Trulicity Injectable, Drug Tier = 3; Requirements & Limits = (PA)(QL)(M)
    ImplicationPrior authorization, quantity limit, and medical necessity review apply — PA must be obtained to ensure coverage.
    Related suppliesTrulicity entries reference associated needle/misc supply lines that may carry (M) flags
    Genotropin Injectable — quantity-limit related entry
    Genotropin InjectableFormulary line: Genotropin Injectable, Drug Tier = 5; Requirements & Limits = (PA)(QL)(M)
    ImplicationPA and QL apply and medical necessity review is indicated — typically a specialty/growth-hormone entry requiring documentation.
    Provider actionSubmit PA and supporting medical necessity documentation for coverage and for requests above quantity limits
    Multiple formulary entries — QL present
    Multiple formulary lines with QLSeveral miscellaneous topical, nebulizer, and device/test product lines include (QL) on their requirements & limits fields.
    ExamplesNebusal Neb and Drysol Solution appear with (QL) or (PA)(QL)(M) depending on product; many device/test kits list (PA)(QL)(M)
    ActionRefer to each product line for the exact QL value and preauthorization requirement when quantities exceed plan limits
    Multiple listed generics and brand entries — QL indicators
    Nicotine and smoking-cessation productsMultiple nicotine products (Cvs Nicotine, Eq Nicotine, Ft Nicotine, Gnp Nicotine, etc.) list (QL)(M)(AGE) or (QL)(M) flags — check specific line for QL details.
    Anticonvulsants and related genericsTopiramate, Valproic Acid, Xcopri, Zonisamide and others show (QL)(M) — quantity limits apply to these entries.
    Thyroid and other genericsVarious generics and brand entries across lines display (QL) indicators next to the product; consult the formulary entry for limits.